Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00220_DB01076_nanopub.RAc9B5en9mHDzyLvzFBdIsAaahwFgFQ7bHgQD2-fvBJUY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00220_DB01076 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00220_DB01076 label "DDI between Nelfinavir and Atorvastatin - Nelfinavir, a strong CYP3A4 inhibitor, may increase the serum concentration of atorvastatin by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of atorvastatin if nelfinavir is initiated, discontinued or dose changed. [drugbank_resource:DB00220_DB01076]" assertion.
- drugbank_resource:DB00220_DB01076 identifier "drugbank_resource:DB00220_DB01076" assertion.
- drugbank_resource:DB00220_DB01076 title "DDI between Nelfinavir and Atorvastatin - Nelfinavir, a strong CYP3A4 inhibitor, may increase the serum concentration of atorvastatin by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of atorvastatin if nelfinavir is initiated, discontinued or dose changed." assertion.
- drugbank:DB00220 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00220_DB01076 assertion.
- drugbank:DB01076 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00220_DB01076 assertion.